|
|
|
|
pmid:
|
Ogbourne SM et al. |
Antitumor activity of 3-ingenyl angelate: plasma membrane and mitochondrial disruption and necrotic cell death. |
2004 |
Cancer Res. |
pmid:15087400
|
Gillespie SK et al. |
Ingenol 3-angelate induces dual modes of cell death and differentially regulates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in melanoma cells. |
2004 |
Mol. Cancer Ther. |
pmid:15634659
|
Hampson P et al. |
PEP005, a selective small-molecule activator of protein kinase C, has potent antileukemic activity mediated via the delta isoform of PKC. |
2005 |
Blood |
pmid:15845901
|
Cozzi SJ et al. |
Induction of senescence in diterpene ester-treated melanoma cells via protein kinase C-dependent hyperactivation of the mitogen-activated protein kinase pathway. |
2006 |
Cancer Res. |
pmid:17047072
|
Challacombe JM et al. |
Neutrophils are a key component of the antitumor efficacy of topical chemotherapy with ingenol-3-angelate. |
2006 |
J. Immunol. |
pmid:17114487
|
|
|
|
|
pmid:17115221
|
|
|
|
|
pmid:17264770
|
|
|
|
|
pmid:18265980
|
Serova M et al. |
Effects of protein kinase C modulation by PEP005, a novel ingenol angelate, on mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling in cancer cells. |
2008 |
Mol. Cancer Ther. |
pmid:18413805
|